• LAST PRICE
    2.3400
  • TODAY'S CHANGE (%)
    Trending Up0.0200 (0.8621%)
  • Bid / Lots
    2.2900/ 1
  • Ask / Lots
    2.5300/ 1
  • Open / Previous Close
    2.2900 / 2.3200
  • Day Range
    Low 2.2700
    High 2.3500
  • 52 Week Range
    Low 1.8700
    High 3.6700
  • Volume
    144,247
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 2.32
TimeVolumeORMP
09:32 ET124232.3
09:35 ET60872.3
09:37 ET150292.3
09:39 ET185582.31
09:42 ET70662.2963
09:44 ET24452.2952
09:46 ET5602.31
09:51 ET31002.2997
09:53 ET68662.29
09:57 ET5002.2998
10:02 ET15002.295
10:04 ET11502.295
10:06 ET30002.2902
10:08 ET2002.29
10:09 ET30002.2996
10:11 ET10002.2907
10:13 ET60002.295
10:15 ET59722.31
10:26 ET7492.31
10:36 ET41402.33
10:38 ET3502.34
10:42 ET8002.3316
10:56 ET5002.331
10:58 ET2002.34
11:05 ET5002.345
11:07 ET1002.345
11:09 ET5002.345
11:12 ET6002.34
11:14 ET7332.34
11:23 ET30002.3402
11:25 ET22592.34
11:50 ET1002.34
12:10 ET1002.33
12:28 ET28342.3358
12:51 ET1002.335
01:11 ET10002.335
01:15 ET1002.33
01:31 ET9002.33
01:38 ET2002.335
01:42 ET51002.335
02:00 ET1002.33
02:45 ET14002.35
02:52 ET2532.3463
03:15 ET9862.35
03:17 ET1002.345
03:21 ET5952.345
03:32 ET1002.345
03:35 ET2002.345
03:37 ET2102.342
03:51 ET3002.35
03:55 ET11002.3401
03:57 ET1002.34
04:00 ET22042.34
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesORMP
Oramed Pharmaceuticals Inc
93.5M
4.7x
---
United StatesCMRX
Chimerix Inc
93.5M
-1.1x
---
United StatesOVID
Ovid Therapeutics Inc
96.5M
-2.9x
---
United StatesRGLS
Regulus Therapeutics Inc
92.4M
-1.4x
---
United StatesGNTA
Genenta Science SPA
88.8M
-9.2x
---
United StatesIFRX
InflaRx NV
90.1M
-1.5x
---
As of 2024-11-12

Company Information

Oramed Pharmaceuticals Inc. is a pharmaceutical company engaged in the research and development of pharmaceutical solutions with a technology platform. The Company has developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its Protein Oral Delivery (POD) technology is designed to protect drug integrity and increase absorption. Its pipeline includes ORMD-0801 (Oral Insulin) Diabetes, ORMD-0801 (Oral Insulin) NASH, and ORMD 0901 (Oral GLP-1). Its oral insulin (ORMD-0801) has the potential to create a new paradigm in the treatment of diabetes through oral delivery of insulin at an earlier stage of treatment. Its oral insulin capsule (ORMD-0801) has shown a reduction of liver fat content in early clinical trials. It is also developing an oral Glucagon-like peptide-1 (GLP-1) analog capsule (ORMD-0901), which is an incretin hormone that stimulates the secretion of insulin from the pancreas.

Contact Information

Headquarters
1185 AVENUE OF THE AMERICAS, 3RD FLOORNEW YORK, NY, United States 10036
Phone
646-844-1164
Fax
845-818-3588

Executives

Chairman of the Board, President, Chief Executive Officer
Nadav Kidron
Chief Financial Officer, Treasurer, Company Secretary
Avraham Gabay
Chief Operating and Business Officer
Joshua Hexter
Chief Scientific Officer, Director
Miriam Kidron
Independent Director
Daniel Aghion

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$93.5M
Revenue (TTM)
$0.00
Shares Outstanding
40.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.69
EPS
$0.50
Book Value
$4.06
P/E Ratio
4.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
4.5x
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.